节点文献

猪endoglin胞外段DNA疫苗诱导抗小鼠结肠癌免疫反应

A DNA Vaccine Encoding the Extracellular Domain of Porcine Endoglin Induces Antitumor Immunity in a Mouse Colon Carcinoma Model

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 焦解歌张阳德黎岳南

【Author】 JIAO Jie-Ge1, ZHANG Yang-De1, LI Yue-Nan2 1. Hepatobiliary and Enteric Surgical Research Center of Health Ministry, Center South University, Changsha, Hunan, 410008, P. R. China 2. Department of Pathology, Hainan Medical College, Haikou, Hainan, 571101, P. R. China

【机构】 中南大学卫生部肝胆肠外科研究中心,中南大学卫生部肝胆肠外科研究中心,海南医学院病理学教研室 湖南长沙410008海南医学院病理学教研室,海南海口571101,湖南长沙410008,海南海口571101

【摘要】 背景与目的:研究表明,endoglin是肿瘤血管生成的标志性分子,用抗endoglin单克隆抗体被动免疫治疗可以有效抑制肿瘤生长,而异种DNA疫苗可以打破自身同源分子的免疫耐受。因此,本研究用猪endoglin胞外段真核表达质粒(ppEDG)作为异种DNA疫苗,了解该DNA疫苗是否具有抑制小鼠结肠癌生长的作用,并探讨其作用的免疫学机理。方法:观察免疫治疗后的荷瘤小鼠肿瘤体积和生存情况,用免疫组化方法(抗CD31)观察肿瘤组织血管生长并计算肿瘤微血管密度,用Westernblot和ELISA方法检测荷瘤小鼠免疫治疗后的血清是否含有抗自身endoglin的抗体以及抗体亚型,用ELISPOT方法检测荷瘤小鼠脾脏中分泌抗自身endoglin抗体的B淋巴细胞。结果:肿瘤接种18天后,ppEDGDNA疫苗主动免疫治疗组肿瘤体积明显小于空质粒(e-p)对照组及生理盐水对照组(P<0.05),存活时间明显延长(P<0.001)。ppEDG组、e-p组和生理盐水组肿瘤组织微血管密度计数分别为19.2±4.5、76.9±14.4和81.4±16.9(P<0.001)。治疗组小鼠血清中含有抗自身endoglin的抗体,抗体亚型主要为IgG1和IgG2b。三组小鼠分泌抗自身endoglin抗体的B淋巴细胞数分别为82.5±14.1、3.6±1.3和4.7±2.0(P<0.001)。结论:ppEDGDNA疫苗诱导抗自身endoglin抗体产生,从而抑制肿瘤血管生成和肿瘤生长。

【Abstract】 BACKGROUND & OBJECTIVE: Endoglin is a marker of tumor angiogenesis. Increasing evidences proved that passive immunotherapy with anti-endoglin monoclonal antibody can effectively inhibit tumor growth, and xenogeneic homologous DNA vaccine can inhibit cross antitumor immunity. This study was to explore the inhibitory effect of a DNA vaccine encoding the extracellular domain of porcine endoglin (ppEDG) on tumor growth in a mouse colon carcinoma model. METHODS: ppEDG was used as a DNA vaccine to actively immunize the colon carcinoma-bearing mice. Tumor volume and survival rate of the mice were observed in 3-day intervals. Microvessel density (MVD) was detected by immunohistochemistry; antibodies against self-endoglin were detected by Western blot and ELISA; the B cells that secrete auto-antibodies against self-endoglin were detected by ELISPOT assay. RESULTS: Eighteen days after tumor cell inoculation, the tumor volume was significantly smaller in ppEDG-immunized group than in empty plasmid (e-p) group and normal saline (NS) group (P<0.05), and the survival time was significantly longer in ppEDG-immunized group than in the control groups (P<0.001). MVD was significantly lower in ppEDG-immunized group than in e-p group and NS group (19.2±4.5 vs. 76.9±14.4 and 81.4±16.9, P<0.001). The antibodies against self-endoglin were identified in ppEDG-immunized group; the major subtypes were IgG1 and IgG2b. The auto-antibody-producing B cells were much more in ppEDG-immunized group than in e-p group and NS group (82.5±14.1 vs. 3.6±1.3 and 4.7±2.0, P<0.001). CONCLUSION: ppEDG DNA vaccine could induce the production of auto-antibodies against self-endoglin, which further inhibit angiogenesis and growth of colon carcinoma.

【关键词】 结肠肿瘤EndoglinDNA疫苗血管生成免疫治疗小鼠
【Key words】 Colon neoplasmsEndoglinDNA vaccineAngiogenesisImmunotherapyPorcineMouse
【基金】 国家自然科学基金项目(No.30360115)~~
  • 【文献出处】 癌症 ,Chinese Journal of Cancer , 编辑部邮箱 ,2005年10期
  • 【分类号】R735.35;
  • 【被引频次】6
  • 【下载频次】81
节点文献中: 

本文链接的文献网络图示:

本文的引文网络